Georgia's biopharmaceutical sector focuses on innovation in drug development and therapy, manifesting a determination to meet evolving healthcare challenges. Companies in this field range from startups to established firms, specializing in areas like neurology, oncology, and vaccine production. At the heart of this industry is a commitment to research, with many companies actively engaged in clinical trials and partnerships. The ongoing rise of biotechnology indicates that the state is poised for robust growth, contributing to global health solutions. Notable advances in delivery systems and therapeutic approaches are shaping the future of medicine here.

The companies featured in this list vary in size, with most employing between 11 and 500 professionals. Many are based in prominent cities like Alpharetta and Atlanta, established since 1986 through 2019. They specialize in areas such as neurology, women's health, and vaccine development. Each company demonstrates a commitment to addressing pressing medical needs and often collaborates with research institutions. As the industry evolves, these companies represent the cutting edge of biopharmaceutical innovation, showcasing a mix of established firms and emerging startups with innovative products.

Continue reading to discover the top biopharmaceutical companies in Georgia.

Top 20 Biopharmaceutical Companies Companies in Georgia

1. NeuroTrauma Sciences, LLC

• Website: neurotraumasciences.com
• Ownership type: Venture Capital
• Headquarters: Alpharetta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, January 2019
• Founded year: 2016
• Headcount: 11-50
• LinkedIn: neurotrauma-sciences-llc

NeuroTrauma Sciences, LLC, founded in 2016 and based in Alpharetta, Georgia, is a clinical stage biopharmaceutical company dedicated to developing innovative therapeutics for stroke and other neurological conditions. The company is focused on addressing significant unmet medical needs in stroke treatment, with its lead products, NTS-104 and NTS-105, targeting acute ischemic stroke and chronic stroke. NeuroTrauma Sciences collaborates with healthcare providers and researchers to enhance patient outcomes through advanced drug development. The company is currently completing Phase 1 trials for NTS-104, which is designed to improve recovery in stroke patients. With a small team of experienced professionals, NeuroTrauma Sciences is positioned to contribute to the advancement of stroke therapeutics and improve the lives of those affected by these conditions.

2. Aruna Bio, Inc.

• Website: arunabio.com
• Ownership type: Venture Capital
• Headquarters: Athens, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), May 2022
• Founded year: 2003
• Headcount: 11-50
• LinkedIn: arunabio-inc

Aruna Bio, Inc., based in Athens, Georgia, is a biotechnology firm founded in 2003. The company specializes in creating therapeutic solutions aimed at central nervous system disorders, particularly through the development of exosome-based therapies and neural stem cell products. Their primary focus is on addressing neurodegenerative diseases, which pose significant challenges to healthcare providers and patients alike. Aruna Bio's commitment to research and development is evident in their innovative pipeline, which includes their flagship product, AB126, designed to cross the blood-brain barrier and target various CNS conditions. The company operates with a strong emphasis on scientific rigor and has established a cGMP facility to support the production of clinical-grade materials. Their team includes experienced professionals with extensive backgrounds in biotechnology, enhancing their capability to advance therapeutic solutions in this critical area of medicine.

3. Saol Therapeutics

• Website: saolrx.com
• Ownership type: Corporate
• Headquarters: Roswell, Georgia, United States (USA)
• Employee distribution: United States (USA) 59%, Ireland 41%
• Latest funding: January 2022
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: saol-therapeutics

Saol Therapeutics, based in Roswell, Georgia, is a privately held pharmaceutical company that specializes in the late-stage clinical development of therapies targeting central nervous system (CNS) disorders and orphan diseases. Founded in 2015, Saol has quickly established itself as a focused organization dedicated to improving treatment options for patients with significant unmet medical needs. The company is currently advancing its pipeline, which includes products like SL-1002 and SL-1009, through late-stage clinical trials. Saol has a strong commitment to collaboration, partnering with healthcare providers and other organizations to enhance the standard of care. Although they have divested from previous commercial products to concentrate on development, their ongoing clinical trials and strategic partnerships reflect their ambition to innovate within the biopharmaceutical industry.

4. Irbm

• Website: irbm.com
• Ownership type: Private
• Headquarters: Rome, Georgia, United States (USA)
• Employee distribution: Italy 97%, United States (USA) 2%
• Latest funding: Other (Debt), $16.3M, April 2022
• Founded year: 2009
• Headcount: 201-500
• LinkedIn: irbm-science-park-s-p-a-

Irbm, founded in 2009 and based in Rome, Georgia, is a private contract research organization (CRO) that specializes in drug discovery and development services. The company offers a comprehensive range of capabilities, including small molecule and peptide drug discovery, as well as antibody drug discovery. Irbm's clientele primarily consists of pharmaceutical and biotechnology companies seeking expert guidance to navigate the complexities of bringing new drugs to market. With a workforce of approximately 296 employees, the company has a significant presence in Italy, where 97% of its employees are located. Irbm has a notable history, having been established as a molecular biology institute in 1990 and later becoming an independent entity in 2009. The company has contributed to the development of several marketed drugs and has delivered over 25 candidates that are now in clinical stages. In 2022, Irbm secured funding amounting to approximately $16.25 million, indicating ongoing investment in their capabilities and growth.

5. Radyus Research

• Website: radyusresearch.com
• Ownership type: Venture Capital
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $200,000, February 2020
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: radyus-research

Radyus Research, based in Atlanta, Georgia, is a drug development organization founded in 2019. The company specializes in providing comprehensive services tailored to the needs of biotech firms and academic startups. Their expertise spans lead optimization, candidate selection, and clinical development, guiding clients through the intricate processes of drug development and regulatory compliance. Radyus Research has worked with over 50 clients across 12 countries, showcasing their international reach and commitment to enhancing project success. The team comprises experienced professionals with backgrounds in pharmaceutical R&D and venture capital, ensuring that they understand the expectations of investors and buyers. They have received seed funding of $200,000, which supports their operations and growth in the competitive biopharmaceutical landscape.

6. Alora Pharmaceuticals, LLC

• Website: alorapharma.com
• Ownership type: Private
• Headquarters: Alpharetta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2011
• Headcount: 501-1000
• LinkedIn: alora-pharmaceuticals-llc

Alora Pharmaceuticals, LLC, based in Alpharetta, Georgia, is a private pharmaceutical company founded in 2011. The company specializes in the manufacturing of essential medicines and healthcare solutions, with a focus on therapeutic areas such as women's health, pain management, endocrinology, and neurology. Alora serves healthcare providers, pharmacies, and patients, aiming to meet pressing health needs through innovative treatments. The company operates a family of companies, including Avion Pharmaceuticals and Acella Pharmaceuticals, which broadens its product portfolio. Alora has made significant strides in the industry, including recent FDA approvals and strategic acquisitions that enhance its capabilities in both branded and generic pharmaceuticals. With a workforce of around 135 employees, Alora is committed to making a tangible impact in the healthcare sector.

7. Advaxia Biologics

• Website: advaxia.com
• Ownership type: Private
• Headquarters: Rome, Georgia, United States (USA)
• Employee distribution: Italy 100%
• Founded year: 2010
• Headcount: 51-200
• LinkedIn: advaxia

Advaxia Biologics, founded in 2010 and based in Rome, Georgia, is a private biopharmaceutical company that specializes in the development and manufacturing of adenovirus-based vaccines and biotherapeutics. With a workforce of approximately 26 employees, Advaxia offers a comprehensive suite of services, including cGMP manufacturing, process development, and quality control. They ensure compliance with stringent regulatory standards, making them a reliable partner for pharmaceutical and biotech companies. Advaxia has been involved in significant projects, such as developing the Ebola Virus Vaccine for GlaxoSmithKline and serving as a testing site for AstraZeneca’s COVID-19 vaccine. Their facility is fully compliant with EMA, FDA, and AIFA regulations, and they maintain a 100% batch approval rate, underscoring their commitment to quality and safety in vaccine production.

8. Athens Research & Technology

• Website: athensresearch.com
• Ownership type: Private
• Headquarters: Athens, Georgia, United States (USA)
• Employee distribution: United States (USA) 90%, Netherlands 10%
• Founded year: 1986
• Headcount: 11-50
• LinkedIn: athens-research-%26-technology

Athens Research & Technology, Inc., founded in 1986 and based in Athens, Georgia, is a biotechnology company that specializes in the purification of human proteins and enzymes. The company serves a variety of clients, including researchers, pharmaceutical scientists, and diagnostic manufacturers, by providing high-quality biological products tailored for applications in inflammation, autoimmune diseases, and cancer research. Their product range includes coagulation factors, enzymes, immunoglobulins, and various other proteins, which are essential for both research and therapeutic purposes. Athens Research operates with a model that emphasizes custom services, allowing them to meet specific client needs effectively. They are ISO9001:2015 certified, which underscores their commitment to quality management in their operations. The company has a small workforce, with around 29 employees, and primarily serves clients in the United States, with a minor presence in the Netherlands.

9. Aavis Pharmaceuticals

• Website: aavispharmaceuticals.com
• Ownership type: Private
• Headquarters: Hoschton, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2015
• Headcount: 51-200
• LinkedIn: aavis-pharmaceuticals

Aavis Pharmaceuticals, based in Hoschton, Georgia, is a private pharmaceutical manufacturer founded in 2015. The company specializes in the development and contract manufacturing of generic drugs, emphasizing research and development to create innovative drug formulations. Aavis is recognized for its expertise in navigating the complexities of drug development and regulatory compliance, serving as a partner to other pharmaceutical companies. Their capabilities include the development of immediate and controlled release oral solid dosage forms, as well as analytical method development and validation services. Aavis operates a state-of-the-art facility that adheres to cGMP standards, ensuring high-quality production processes. The company is committed to improving patient outcomes through the development of niche generic drugs and innovative drug delivery systems.

10. Metrics Inc

• Website: metricsinc.com
• Ownership type: Corporate
• Headquarters: Atlanta, Georgia, United States (USA)
• Latest funding: October 2012
• Founded year: 1994
• Headcount: 11-50
• LinkedIn: metrics-inc

Metrics Inc, operating under the name Catalent, was founded in 1994 and is based in Atlanta, Georgia. The company specializes in contract development and manufacturing services tailored for the pharmaceutical and biotechnology sectors. Catalent offers a comprehensive suite of solutions that includes drug development, manufacturing, and clinical supply services. Their expertise helps clients navigate the intricate processes involved in bringing new therapies to market. With a workforce of approximately 41 employees, Metrics Inc plays a vital role in supporting both established pharmaceutical companies and emerging biotech firms. Their services are crucial for optimizing drug formulations and ensuring efficient production processes, which are essential for successful clinical trials and product launches.

11. Galt Pharmaceuticals

• Website: galtrx.com
• Ownership type: Private
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2016
• Headcount: 11-50
• LinkedIn: galtrx

Galt Pharmaceuticals, founded in 2016 and based in Atlanta, Georgia, is a private pharmaceutical company dedicated to developing and commercializing prescription medications that meet unmet clinical needs. With a workforce of approximately 42 employees, Galt operates under a unique business model that prioritizes patient-centric partnerships with healthcare providers. The company aims to enhance the quality of life for patients through innovative products and offers support programs for those facing financial hardships. Galt's product portfolio includes medications such as Norgesic, Tolectin, Doral, and Oravig, which target various therapeutic areas. The company is committed to addressing gaps in treatment options and ensuring that patients have access to necessary medications, particularly those who may struggle with out-of-pocket costs. Galt's leadership team brings extensive experience in the pharmaceutical industry, further solidifying its position as a relevant player in the biopharmaceutical field.

12. Avion Pharmaceuticals

• Website: avionrx.com
• Ownership type: Private
• Headquarters: Alpharetta, Georgia, United States (USA)
• Employee distribution: United States (USA) 92%, South Africa 3%, France 3%, Other 3%
• Founded year: 2011
• Headcount: 51-200
• LinkedIn: avion-pharmaceuticals

Avion Pharmaceuticals, founded in 2011 and based in Alpharetta, Georgia, is a private pharmaceutical company dedicated to the development and marketing of innovative prescription pharmaceuticals and dietary supplements. The company specializes in therapeutic areas such as women's health, hematology, endocrinology, and dermatology. Avion's product portfolio includes prescription prenatal supplements, low-dose birth control, menopause support, and iron supplements designed for optimized absorption. Their focus on addressing specific medical needs reflects a commitment to improving patient outcomes. With a team that boasts over 90 years of combined experience in the pharmaceutical industry, Avion is well-positioned to identify and enhance the market potential of innovative health solutions. Their customer base includes healthcare professionals and patients seeking effective health solutions, underscoring their relevance in the biopharmaceutical sector.

13. Sebela Pharmaceuticals Inc.

• Website: sebelapharma.com
• Ownership type: Private Equity
• Headquarters: Roswell, Georgia, United States (USA)
• Employee distribution: United States (USA) 92%, Ireland 8%
• Latest funding: January 2016
• Founded year: 2013
• Headcount: 201-500
• LinkedIn: sebela-pharmaceuticals-llc

Sebela Pharmaceuticals Inc., founded in 2013 and based in Roswell, Georgia, is a private equity-backed pharmaceutical company. It specializes in developing and marketing innovative therapeutic options for gastrointestinal diseases and women's health. The company is dedicated to improving patient outcomes through effective treatments and has a strong focus on research and development. Sebela's product portfolio includes market-recognized medications such as SUTAB® and SUPREP® Bowel Prep Kit, which are aimed at gastroenterologists and other specialists. Their acquisition of Braintree Laboratories in 2018 has significantly enhanced their capabilities in the gastroenterology space, allowing them to offer a range of bowel preparation products. Sebela is also advancing its pipeline with investigational products in both gastroenterology and women's health, including contraceptive options. With a workforce of around 200 employees, Sebela operates primarily in the United States, with a small presence in Ireland.

14. Recro

• Website: recrocdmo.com
• Ownership type: Private
• Headquarters: Gainesville, Georgia, United States (USA)
• Founded year: 1982
• Headcount: 201-500
• LinkedIn: recrocdmo

Recro, also known as Societal CDMO, is a private Contract Development and Manufacturing Organization based in Gainesville, Georgia. Founded in 1982, the company has built a reputation for providing comprehensive pharmaceutical services. Their offerings include clinical trial services, cGMP manufacturing, and formulation development, which are essential for pharmaceutical and biotechnology companies navigating the complexities of drug development. Recro emphasizes operational excellence and continuous improvement, focusing on the importance of people and culture in achieving long-term success. They are committed to ensuring compliance with industry regulations while improving the lives of patients through their services. With a workforce of 201-500 employees, Recro is positioned to support a range of clients in the biopharmaceutical industry.

15. Micron Biomedical

• Website: micronbiomedical.com
• Ownership type: Venture Capital
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $16.0M, January 2025
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: micron-biomedical-inc.

Micron Biomedical, founded in 2014 and based in Atlanta, Georgia, is a clinical-stage life sciences company dedicated to enhancing access to vaccines and therapeutics worldwide. The company specializes in innovative delivery systems, particularly through its proprietary dissolvable microarray technology, which allows for painless, needle-free administration of vaccines and medications. This technology not only simplifies the process for patients but also reduces the need for cold chain logistics, thereby minimizing costs and waste. Micron Biomedical has been recognized for its potential impact on global health, particularly in areas where traditional vaccine delivery methods pose challenges. The company has recently secured significant funding, including a $23.6 million investment aimed at accelerating the commercial manufacturing of its needle-free vaccines. Their ongoing clinical trials, including positive results published in reputable journals, further underscore their active role in the biopharmaceutical industry.

16. Stage Analytics

• Website: stageanalytics.com
• Ownership type: Private
• Headquarters: Suwanee, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2017
• Headcount: 11-50
• LinkedIn: monumentanalytics

Stage Analytics, founded in 2017 and based in Suwanee, Georgia, is a private consulting firm focused on enhancing health outcomes in the life sciences sector. With a team of 26 professionals, the company specializes in health economics and outcomes research (HEOR), project management, and innovation and education services. They partner with clients in pharmaceuticals, biotechnology, and medical devices to streamline access to treatments and improve patient outcomes. Their expertise aids clients in effectively communicating the value of their innovations to payers and stakeholders, thereby facilitating better market access. Stage Analytics is committed to advancing healthcare through scientific solutions and has a strong emphasis on collaboration and integrity in their operations.

17. T3 Labs - Translational Testing and Training Laboratories, Inc.

• Website: gcmiatl.com
• Ownership type: Private
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1999
• Headcount: 51-200
• LinkedIn: t3-labs---translational-testing-and-training-laboratories-inc-

T3 Labs - Translational Testing and Training Laboratories, Inc., based in Atlanta, Georgia, operates as a contract research organization (CRO) with a focus on medical technology. Founded in 1999, the company provides essential services such as preclinical testing, bioskills training, and lifecycle advisory to medical device and pharmaceutical developers. Their expertise spans various areas, including cardiovascular, orthopedic, and regenerative medicine, ensuring that innovations meet both regulatory standards and market needs. T3 Labs also offers facilities for prototyping and testing, which are compliant with industry standards. By assisting clients in navigating the complexities of the commercialization process, T3 Labs plays a vital role in bringing medical innovations to market, thereby enhancing healthcare delivery and patient outcomes.

18. Purisys

• Website: purisys.com
• Ownership type: Private
• Headquarters: Athens, Georgia, United States (USA)
• Employee distribution: United States (USA) 93%, United Kingdom (UK) 7%
• Founded year: 2019
• Headcount: 51-200
• LinkedIn: purisys

Purisys, founded in 2019 and based in Athens, Georgia, is a private pharmaceutical manufacturer that specializes in custom Active Pharmaceutical Ingredients (APIs) and CDMO services. The company supports biotech and pharmaceutical firms throughout the drug development process, offering a range of services that include process development, analytical capabilities, and small-scale manufacturing. With a workforce of approximately 30 employees, Purisys operates from a GMP-compliant facility that is FDA inspected, ensuring adherence to high-quality standards. They have a global supply chain and export to over 40 countries, meeting international regulatory compliance requirements. Notably, Purisys has carved out a niche in the production of cannabinoid and psychedelic APIs, reflecting their commitment to addressing emerging therapeutic needs. Their extensive experience in commercial pharmaceutical production, spanning over 40 years, enhances their capability to assist clients from pre-clinical stages to market entry.

19. NeuroTrials Research

• Website: neurotrials.com
• Ownership type: Private
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1997
• Headcount: 11-50
• LinkedIn: neurotrials-research-inc-

NeuroTrials Research, Inc. is a clinical research organization based in Atlanta, Georgia, founded in 1997. The company specializes in conducting Phase I-IV clinical trials, focusing primarily on neurological and sleep disorders. They provide comprehensive services to pharmaceutical companies and device manufacturers, managing the entire trial process from participant recruitment to regulatory compliance. With a team of experienced clinical investigators, NeuroTrials has successfully conducted hundreds of studies, engaging over 3,000 volunteers from the Atlanta area and its suburbs. Their research areas include Alzheimer's disease, Parkinson's disease, sleep disorders, and various psychiatric conditions. NeuroTrials operates a state-of-the-art facility equipped for advanced clinical research, ensuring high standards of patient care and data integrity. They have built a robust patient database and utilize a variety of marketing strategies to attract participants for their studies.

20. Peachtree BioResearch Solutions

• Website: peachtreebrs.com
• Ownership type: Private
• Headquarters: Marietta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2008
• Headcount: 51-200
• LinkedIn: peachtree-bioresearch-solutions

Peachtree BioResearch Solutions, founded in 2008 and based in Marietta, Georgia, is a clinical research organization dedicated to providing comprehensive clinical development services. The company primarily serves biotechnology, pharmaceutical, and medical device firms, focusing on small to mid-sized sponsors. Peachtree offers a wide array of services, including study feasibility, clinical monitoring, data management, biostatistics, and quality assurance. Their team consists of experienced professionals who have worked on numerous clinical trials, ranging from Phase I studies to global multi-center trials. Peachtree's operational philosophy emphasizes a solutions-based approach, ensuring that clients receive tailored support throughout the clinical trial process. Their commitment to minimizing turnover and maintaining stable project teams enhances their ability to deliver consistent and reliable results. With a strong emphasis on quality and compliance, Peachtree BioResearch Solutions plays a significant role in the clinical research landscape, making them a noteworthy player in the biopharmaceutical industry.

Biopharmaceutical Companies Insights: Key Companies in Georgia

Want to Find More Biopharmaceutical Companies Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!